Login/Register

Exane BNP Paribas downgrades BBVA

International

Exane BNP Paribas downgrades BBVA

Wed, 15 February 2012
Exane BNP Paribas downgrades BBVA
Banco Bilbao Vizcaya Argentaria Quote more

Price: 9.39

Chg: 0.07

Chg %: 0.70%

Date:

IBEX 35 Quote

Price: 11,640.20 Chg: 134.80 Chg %: 1.17% Date:

Analysts at Exane BNP Paribas have downgraded their recommendation for BBVA to underweight from overweight.

The analysts also lowered Bankia's price target from €3.30 to €2.

Digital Look has given its own views on both Spanish stocks and sees a bullish outlook for BBVA, but a bearish outlook for Bankia:

BBVA TECHNICAL OUTLOOK

We have seen a substantial improvement in BBVA's stock performance after breaking out of resistance at €7. That resistance level also coincided with the 200-day moving average and thus it is likely that we will see a change of trend.

For the short-term, we expect some price consolidation although the excellent accumulation levels lead us to believe that the gains will continue towarsd at least €8.

BANKIA TECHNICAL OUTLOOK

The stock chart for Bankia reveals a very bearish technical outlook as the stock fell below the support level at €3.50. That support level was the bottom part of a trading range in which it has been trading for several months. We now expect a return to the November low of €3.12."

"We do not expect any bullish signals as long as it trades below €3.63.


BBVA was up 0.36% to €7.15 while Bankia showed a 1.01% loss to €3.41 this morning.

MJ.J/C.N.

NASDAQ 100 Top Risers

Name Last Chg.% Time
Tesla Motors Inc 231.55 6.01 21:25
Fastenal Co. 42.41 1.87 21:25
Apple Inc. 132.65 1.82 21:25
Akamai Technologies Inc. 77.04 1.72 21:25
Baidu Inc. 220.56 1.69 21:16

NASDAQ 100 Top Fallers

Name Last Chg.% Time
Applied Materials Inc. 19.97 -8.39 21:25
Mylan Inc. 71.72 -5.71 21:22
Mattel Inc. 28.80 -4.64 21:25
Vertex Pharmaceuticals Inc. 127.88 -3.99 21:25
Celgene Corp. 114.71 -3.37 21:25